Ikarian Capital, LLC Blueprint Medicines Corp Call Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 13, 2022
BUY
$54.1 - $110.08 $3.46 Million - $7.05 Million
64,000 New
64,000 $4.09 Million
Q3 2020

Nov 16, 2020
SELL
$66.45 - $92.7 $8.53 Million - $11.9 Million
-128,400 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$57.09 - $79.27 $4.48 Million - $6.21 Million
78,400 Added 156.8%
128,400 $10 Million
Q1 2020

May 15, 2020
BUY
$48.11 - $82.22 $2.41 Million - $4.11 Million
50,000 New
50,000 $2.92 Million

Others Institutions Holding BPMC

# of Institutions
352
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.48B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email